Hyderabad: World Health Organization (WHO) will make a last call on the Bharat Biotech application used emergency (EUL) for Covaxin Covid-19 vaccine which is originally advanced next week, said the global health agency on Tuesday night.
“Who & a group of independent experts are scheduled to meet next week to carry out the risk / benefit assessment and achieve the final decision whether it will provide an emergency use list to Covaxin,” which tweeted after a meeting of the strategic consultation group (Sage) to discuss the Covaxin EUL application.
Covaxin manufacturer, Bharat Biotech, has sent data to who is rolling & sends …
https://t.co/6QZLO4PTD- The World Health Organization (WHO) (@sho) 1633444570000 “Manufacturer of Covaat, Bharat Biotech, has been sending Data to whom with the basic rolling & send additional info on the request on September 27.
Who is the expert currently reviewing this info & if it discusses all the questions raised, whose assessment will be completed next week, “said who.
Which also shows that the EUL process carried out by WHO and the technical advisory group of independent experts centered on determining whether the products are produced, such as vaccines, safe, safe and effective.
On September 29, which has updated the date of the decision for Covaxin EUL until October 2021 in the latest EUL guide document for the Covid-19 vaccine from the status “has not been confirmed”.